Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial

Published:2013-05 Issue:19 Volume:61 Page:1998-2006
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Piccini Jonathan P.,Stevens Susanna R.,Lokhnygina Yuliya,Patel Manesh R.,Halperin Jonathan L.,Singer Daniel E.,Hankey Graeme J.,Hacke Werner,Becker Richard C.,Nessel Christopher C.,Mahaffey Kenneth W.,Fox Keith A.A.,Califf Robert M.,Breithardt Günter

Funder

Johnson & Johnson

AstraZeneca

Bayer

Boehringer-Ingelheim

Bristol-Myers Squibb

Daiichi Sankyo

Eli Lilly

GlaxoSmithKline

Merck

Momenta Pharmaceuticals

Novartis

Portola

Pozen

Regado Biotechnologies

Sanofi-Aventis

Schering-Plough

The Medicines Company

Lilly

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines;Wann;J Am Coll Cardiol,2011

2. Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion;Gallagher;J Am Coll Cardiol,2002

3. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion;Nagarakanti;Circulation,2011

4. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

5. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation: rationale and design of the ROCKET AF study;Am Heart J,2010

Cited by 236 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elective Direct Current Cardioversion of Atrial Fibrillation: Silent Brain Infarction and Health-Related Quality of Life;Cardiology;2024-08-01

2. Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures;Journal of the American College of Cardiology;2024-01

3. Non-Vitamin K Antagonist Oral Anticoagulants in Differentiated Approach to the Use in Cardiological Practice: Literature Review;Ukrainian Journal of Cardiovascular Surgery;2023-09-28

4. Electric cardioversion in patients treated with oral anticoagulants: embolic material in the left atrial appendage;Cardiovascular Journal of Africa;2023-09-01

5. Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association;Circulation;2023-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3